Literature DB >> 24500451

Irritable bowel syndrome may be associated with maternal inheritance and mitochondrial DNA control region sequence variants.

Miranda A L van Tilburg1, Essam A Zaki, Thangam Venkatesan, Richard G Boles.   

Abstract

BACKGROUND AND AIM: Mitochondrial dysfunction has been implicated in various functional disorders that are co-morbid to irritable bowel syndrome (IBS) such as migraine, depression and chronic fatigue syndrome. The aim of the current case-control pilot study was to determine if functional symptoms in IBS show a maternal inheritance bias, and if the degree of this maternal inheritance is related to mitochondrial DNA (mtDNA) polymorphisms.
METHODS: Pedigrees were obtained from 308 adult IBS patients, 102 healthy controls, and 36 controls with inflammatory bowel disease (IBD), all from Caucasian heritage, to determine probable maternal inheritance. Two mtDNA polymorphisms (16519T and 3010A), which have previously been implicated in other functional disorders, were assayed in mtDNA haplogroup H IBS subjects and compared to genetic data from 344 published haplogroup H controls.
RESULTS: Probable maternal inheritance was found in 17.5 % IBS, 2 % healthy controls and 0 % IBD controls (p < .0001). No difference was found between IBS and control for 3010A, and a trend was found for 16519T (p = 0.05). IBS with maternal inheritance were significantly more likely to have the 16519T than controls (OR 5.8; 95 % CI 1.5-23.1) or IBS without maternal inheritance (OR 5.2; 95 % CI 1.2-22.6).
CONCLUSIONS: This small pilot study shows that a significant minority (1/6) of IBS patients have pedigrees suggestive of maternal inheritance. The mtDNA polymorphism 16519T, which has been previously implicated in other functional disorders, is also associated with IBS patients who display maternal inheritance. These findings suggest that mtDNA-related mitochondrial dysfunction may constitute a sub-group within IBS. Future replication studies in larger samples are needed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24500451      PMCID: PMC4071137          DOI: 10.1007/s10620-014-3045-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial.

Authors:  P S Sándor; L Di Clemente; G Coppola; U Saenger; A Fumal; D Magis; L Seidel; R M Agosti; J Schoenen
Journal:  Neurology       Date:  2005-02-22       Impact factor: 9.910

2.  Mitochondrial energy depletion in depression with somatization.

Authors:  Ann Gardner; Richard G Boles
Journal:  Psychother Psychosom       Date:  2008-01-25       Impact factor: 17.659

3.  Mitochondrial inheritance in depression, dysmotility and migraine?

Authors:  Brittany B Burnett; Ann Gardner; Richard G Boles
Journal:  J Affect Disord       Date:  2005-09       Impact factor: 4.839

4.  Migraine without aura and migraine with aura are inherited disorders.

Authors:  M B Russell; L Iselius; J Olesen
Journal:  Cephalalgia       Date:  1996-08       Impact factor: 6.292

5.  Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine.

Authors:  Andrew D Hershey; Scott W Powers; Anna-Liisa B Vockell; Susan L Lecates; Priscilla L Ellinor; Ann Segers; Danny Burdine; Paula Manning; Marielle A Kabbouche
Journal:  Headache       Date:  2007-01       Impact factor: 5.887

6.  Magnetic resonance spectroscopy in migraine.

Authors:  P Montagna
Journal:  Cephalalgia       Date:  1995       Impact factor: 6.292

7.  Reflex sympathetic dystrophy: complex regional pain syndrome type I in children with mitochondrial disease and maternal inheritance.

Authors:  T Higashimoto; E E Baldwin; J I Gold; R G Boles
Journal:  Arch Dis Child       Date:  2008-01-11       Impact factor: 3.791

8.  Comorbidity in irritable bowel syndrome.

Authors:  William E Whitehead; Olafur S Palsson; Rona R Levy; Andrew D Feld; Marsha Turner; Michael Von Korff
Journal:  Am J Gastroenterol       Date:  2007-09-26       Impact factor: 10.864

9.  Psychiatric comorbidity in 36 adults with mitochondrial cytopathies.

Authors:  Omar Fattal; Jessica Link; Kathleen Quinn; Bruce H Cohen; Kathleen Franco
Journal:  CNS Spectr       Date:  2007-06       Impact factor: 3.790

10.  An enhanced MITOMAP with a global mtDNA mutational phylogeny.

Authors:  Eduardo Ruiz-Pesini; Marie T Lott; Vincent Procaccio; Jason C Poole; Marty C Brandon; Dan Mishmar; Christina Yi; James Kreuziger; Pierre Baldi; Douglas C Wallace
Journal:  Nucleic Acids Res       Date:  2006-12-18       Impact factor: 16.971

View more
  4 in total

Review 1.  Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model.

Authors:  Jonas Blomberg; Carl-Gerhard Gottfries; Amal Elfaitouri; Muhammad Rizwan; Anders Rosén
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561

2.  Mitochondrial modulation-induced activation of vagal sensory neuronal subsets by antimycin A, but not CCCP or rotenone, correlates with mitochondrial superoxide production.

Authors:  Katherine R Stanford; Thomas E Taylor-Clark
Journal:  PLoS One       Date:  2018-05-07       Impact factor: 3.240

Review 3.  Inflammation/bioenergetics-associated neurodegenerative pathologies and concomitant diseases: a role of mitochondria targeted catalase and xanthophylls.

Authors:  Mikhail A Filippov; Olga G Tatarnikova; Natalia V Pozdnyakova; Vasily V Vorobyov
Journal:  Neural Regen Res       Date:  2021-02       Impact factor: 5.135

4.  A genetic polymorphism that is associated with mitochondrial energy metabolism increases risk of fibromyalgia.

Authors:  Miranda A L van Tilburg; Marc Parisien; Richard G Boles; Gillian L Drury; Julian Smith-Voudouris; Vivek Verma; Samar Khoury; Anne-Julie Chabot-Doré; Andrea G Nackley; Shad B Smith; William E Whitehead; Denniz A Zolnoun; Gary D Slade; Inna Tchivileva; William Maixner; Luda Diatchenko
Journal:  Pain       Date:  2020-12       Impact factor: 7.926

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.